- Lunit to support MD Anderson researchers studying immune phenotype biomarkers for pembroliz...
* Memorandum of Understanding to be inked between Lunit and Seha Virtual Hospital, marking a new ...
* Lunit SCOPE IO pivotal in first phase III trial successfully showing the efficacy of immunother...
- Nine abstracts, featuring the effectiveness of Lunit's AI-powered TIL/WSI analyzer and biomarker ...
- 9 abstracts accepted by the ESMO annual meeting - unveiling insights into cancer analysis, immuno...
- Lunit's 6 posters unveil new tumor microenvironment insights and the predictive power of Lunit SC...
* Lunit's collaborative study supports AI as a viable alternative to one human reader inEurope's ...
- Lunit's collaborative study supports AI as a viable alternative to one human reader inEurope's do...
- A collaborative study demonstrates that AI analysis of Tertiary Lymphoid Structures (TLS) in tumo...
- Collaborative study with NCCHE shows that AI analysis of HER2 expression and the tumor microenvir...
Lunit strengthens presence in the Middle East by supplying AI-powered breast screening solution to ...
* Lunit's AI-powered cancer screening solutions have been selected for Seha Virtual Hospital's AI...
- Recent study conducted by Seoul National University Hospital provides strong evidence that high-a...
- Medical AI solutions, including CXR-AID, officially included in Japanese health insurance reimbur...
- Lunit's pioneering AI study to be unveiled at one of the premier computer vision conferences, inn...
- Lunit and Sweden's largest private hospital pioneering a new approach to combine radiologists' ex...
* Collaborative research with Japan's largest oncology practice shows Lunit SCOPE's potential in ...
- New studies reveal Lunit SCOPE's impact on predicting clinical outcomes, analyzing tumor microenv...
- Lunit and collaborators demonstrate the predictive value and analytical prowess of Lunit's AI-bi...
* Lunit and collaborators demonstrate key progress in the development of novel diagnostics for ca...
